We are in the unique position to offer:
- Chemical synthesis of linkers and payloads
- Development, optimization and manufacturing services for mammalian and microbial derived proteins
- Support for the preclinical lead generation using state of the art, scalable conjugation technologies and analytical methods
- Process development, process optimization and scale up as well as BLA activities like process characterizations and PPQ supporting studies and assessments
- Manufacturing of material for toxicology studies using representative process
- Formulation development (liquid and lyophilized) and drug product development
- Regulatory consulting and writing of relevant sections of INDs and BLAs
We have experience with a wide range of bioconjugation technologies including the synergistic pooling of large and small molecule manufacturing practices to achieve delivery. We can help you minimize risk, time cost and supply chain complexity.
Our locations
Locations where this service is provided
Visp, Switzerland
Founded in 1897, Lonza today is a dedicated strategic manufacturing partner to the healthcare industry, working with customers in the pharma, biotech and nutrition markets. Visp remains our largest site in a global network of more than 30 sites and one of the most significant for research and development and manufacturing.
Our Visp site is a complex of industry-leading facilities specializing in the development and manufacture of products for pharmaceutical applications including mammalian and microbial biopharmaceuticals, small molecules, highly potent APIs, peptides and bioconjugates including antibody-drug conjugates (ADCs). It is also home to our pioneering Ibex® Solutions services offering. Ibex® Solutions enables customers to accelerate their path throughout the complete biopharmaceutical lifecycle - from preclinical to commercial stages, from drug substance to drug product, all in one location.